Form 4: Harte Hanks CFO David A. Garrison Reports Significant Equity Grants and Stock Holdings

Harte Hanks Inc.'s Chief Financial Officer, David A. Garrison, reported the acquisition of 25,000 restricted stock units and 64,600 non-qualified stock options, alongside existing holdings in his retirement account.

Summary

• David A. Garrison, Chief Financial Officer of Harte Hanks Inc. (HHS), reported new equity grants and existing beneficial ownership.
• Acquired 25,000 Restricted Stock Units (RSUs) on June 2, 2025, at a price of $4.55 per share.
• These 25,000 RSUs will vest in three equal annual tranches on the anniversary of the grant date.
• Granted 64,600 Non-Qualified (NQ) stock options on January 29, 2024, with an exercise price of $7.74.
• These 64,600 NQ stock options will vest 33% annually on January 29, 2025, January 29, 2026, and January 29, 2027.
• Beneficially owns 13,129 shares of Common Stock held in a participant's retirement account.

Sentiment

Score: 7

Explanation: The document indicates a positive alignment of management's interests with shareholders through significant equity grants, which is generally viewed favorably. It is a routine disclosure of compensation.

Positives

• Significant equity grants to the Chief Financial Officer align management's interests with shareholders, promoting long-term value creation.
• The acquisition of 25,000 Restricted Stock Units (RSUs) at $4.55 per share indicates a direct equity stake and commitment.
• The grant of 64,600 Non-Qualified stock options provides a performance-based incentive for executive leadership.

Future Outlook

The document primarily details past and future vesting schedules for equity grants, indicating a long-term incentive structure for the Chief Financial Officer.

Industry Context

This Form 4 filing reflects standard executive compensation practices within publicly traded companies, where equity grants like RSUs and stock options are used to align executive interests with shareholder value creation and provide long-term incentives. It does not provide broader industry trends.

Stakeholder Impact

• Shareholders: The equity grants to the CFO align his financial interests with shareholder value creation, potentially leading to more focused long-term performance.

Next Steps

• Vesting of 25,000 Restricted Stock Units in three equal annual tranches starting June 2, 2025.
• Vesting of 64,600 Non-Qualified stock options in three 33% tranches on January 29, 2025, 2026, and 2027.
• Potential exercise of Non-Qualified stock options by January 29, 2034.

Key Dates

Recommendation

Keywords

Harte Hanks Inc., HHS, SEC Form 4, Insider Transaction, Stock Options, Restricted Stock Units, CFO, Equity Grant, Beneficial Ownership, Executive Compensation